NYU Langone at #NASBS2025! Our experts are in New Orleans Feb. 13–16, sharing cutting-edge insights on skull base surgery. Don’t miss their sessions —full schedule here:

After 15 years of struggling with SUI, one patient found relief with a novel, non-surgical solution. Dr. Benjamin Brucker (@PelvicMedicine) shares how this FDA-cleared device is changing lives. #WomensHealth #stressurinaryincontinence

NYU Langone’s Dr. Shane Liddelow [@LiddelowSA] is uncovering how astrocytes—critical to brain health—can turn deadly in diseases like dementia. After surviving an aneurysm, his mission is personal: develop life-changing therapies. Discover more —watch now.

Dementia cases in the U.S. could double by 2060. Who’s most at risk—and why? @NatureMedicine #dementia #brainhealth

📍 Dr. Anne S. Renteria joins Perlmutter Cancer Center—Long Island as site director of the Transplantation & Cellular Therapy Program, bringing world-class treatment closer to home. Read: #CancerCare

RT @nyulangone: At NYU Langone Health, we believe that better health starts with a better health system. And we don’t just aspire to be a b…

Dive into the study here: #alzheimers #Neuroscience ✍️ @Nature Molecular Psychiatry

Meet COBRA: An AI tool transforming #stroke rehab. Detects motor impairments after stroke in under 1 min—faster than FMA. Developed by @nyulangone, it’s paving the way for real-time, data-driven recovery. Read more at Physician Focus: ✍️ @npjDigitalMed

NYU Langone Health is rolling out a new systematic approach to diagnosing and treating placenta accreta, a serious pregnancy complication that causes severe bleeding. Read more on Physician Focus. #obgyn

NYU Langone urologist Hossein Sadeghi-Nejad [@Hossein5555], professor of urology and obstetrics and gynecology, highlights the successful use of TURED to treat a 28-year-old male with infertility caused by a recurrent midline prostatic cyst. #Urology

RT @nyugsom_iehe: "We want to reach a point where the technology we’re building is light, largely unseen and has all the necessary performa…

RT @EpilepsyFdn: Dr. Jackie French, Chief Medical and Innovation Officer and Research Editor for the Epilepsy Foundation, shares valuable i…

Congratulations, @DrJordanAxelrad recipient of this year’s Sherman Emerging Leader Prize! The award recognizes early accomplishments and the promise of future contributions to the field of inflammatory bowel disease. #AIBD2024

Researchers @nyulangone and Perlmutter Cancer Center have developed SpotCheck, a new tool for remotely examining and flagging potentially cancerous skin lesions. A new study finds it’s just as accurate in identifying melanoma as an in-person evaluation.

Women who take low doses of minoxidil during or after breast cancer treatment may see hair regrowth without experiencing severe cardiovascular side effects, a team of dermatologists @nyugrossman reports. Their study is published online in @JAAD.

How does caregiving stress impact blood pressure in younger black women? @nyugrossman research uncovers surprising findings. Learn more here: @hypertensionAHA @American_Heart

A new @ScienceMagazine study reveals how multiple phages coexist on a single bacterial strain, each carving out a unique niche. These insights could inform the design of phage cocktails to overcome antibiotic resistance. Uncover the findings here:

Congratulations, @DrJordanAxelrad recipient of this year’s Sherman Emerging Leader Prize! The award recognizes early accomplishments and the promise of future contributions to the field of inflammatory bowel disease. #IABD2024

NYU Langone urologic oncologist Dr. Katie S. Murray describes the successful use of UGN-101 (Jelmyto) in a 91-year-old woman with a history of urothelial carcinoma and a new tumor obstructing her right ureter. Learn more about the case: